CHRYSALIS BIOTHERAPEUTICS, INC.
US UEI XW1VFGGRLDW3 · SME
6public awards
$8.1Mtotal public funding
2016-04-15latest award
State aid awards (6)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2016-04-15 | $3.0M | Grant | TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure | Department of Health and Human Services |
| 2013-01-01 | $1.5M | Grant | SBIR Topic 291 | Department of Health and Human Services |
| 2012-01-01 | $2.8M | Grant | TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure | Department of Health and Human Services |
| 2011-01-01 | $200k | Grant | TAS::75 0849::TAS | Department of Health and Human Services |
| 2011-01-01 | $300k | Grant | Prevention of Allergic Rhinitis with Topical Immunomodulating Antibodi | Department of Health and Human Services |
| 2010-01-01 | $297k | Grant | TP508:A New Drug for Mitigating Lethal Effects of Radiation Exposure | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →